The intracellular distribution of inositol polyphosphates in HL60 promyeloid cells.
1. HL60 promyeloid cells contain high intracellular concentrations of inositol polyphosphates, notably inositol 1,3,4,5,6-pentakisphosphate (InsP5) and inositol hexakisphosphate (InsP6). To determine their intracellular location(s), we studied the release of inositol (poly)phosphates, of ATP, and of cytosolic and granule-enclosed enzymes from cells permeabilized by four different methods. 2. When cells were treated with digitonin, all of the inositol phosphates were released in parallel with the cytosolic constituents. Most of the InsP5 and InsP6 was released before significant permeabilization of azurophil granules. 3. Similar results were obtained from cells preloaded with ethylene glycol and permeabilized by osmotic lysis. 4. Electroporation at approximately 500 V/cm caused rapid release of free inositol. Higher field strengths provoked release of most of the ATP, InsP5 and InsP6, but only slight release of the intracellular enzymes. Multiple discharges released approximately 80-90% of total InsP5 and InsP6. In the absence of bivalent-cation chelators, InsP5 and InsP6 were released less readily than ATP. 5. Treatment of cells with Staphylococcus aureus alpha-toxin caused quantitative release of inositol and ATP, without release of intracellular enzymes. However, inositol phosphates were released much less readily than inositol or ATP. Even after prolonged incubation with a high concentration of alpha-toxin, only approximately 50-70% of InsP2, InsP3 and InsP4 and < or = 20% of InsP5 and InsP6 were released, indicating that the high charge or large hydrated radius of InsP5 and InsP6 might limit their release through small toxin-induced pores. 6. These results indicate that most intracellular inositol metabolites are either in, or in rapid exchange with, the cytosolic compartment of HL60 cells. However, they leave open the possibility that a small proportion of cellular InsP5 and InsP6 (< or = 10-20%) might be in some intracellular bound form.
Stuart
J A
JA
School of Biochemistry, University of Birmingham, Edgbaston, U.K.
Anderson
K L
KL
French
P J
PJ
Kirk
C J
CJ
Michell
R H
RH
D000255:Adenosine Triphosphate / Q000378:metabolism; D001427:Bacterial Toxins / Q000494:pharmacology; D002463:Cell Membrane Permeability / Q000187:drug effects; D002614:Chelating Agents / Q000494:pharmacology; D003600:Cytosol / Q000378:metabolism* / Q000648:ultrastructure; D004072:Digitonin / Q000494:pharmacology; D018274:Electroporation; D019855:Ethylene Glycol; D005026:Ethylene Glycols / Q000494:pharmacology; D006460:Hemolysin Proteins / Q000494:pharmacology; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000378:metabolism; D008854:Microscopy, Electron; D009997:Osmotic Pressure; D010734:Phosphogluconate Dehydrogenase / Q000378:metabolism; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism*; D010833:Phytic Acid / Q000378:metabolism*; D013211:Staphylococcus aureus / Q000378:metabolism; D014407:Tumor Cells, Cultured; D001616:beta-Galactosidase / Q000378:metabolism
D001427:Bacterial Toxins; D002614:Chelating Agents; D005026:Ethylene Glycols; D006460:Hemolysin Proteins; C021091:staphylococcal alpha-toxin; D010833:Phytic Acid; D000255:Adenosine Triphosphate; D010734:Phosphogluconate Dehydrogenase; C072095:inositol 1,3,4,5,6-pentakisphosphate-1-3-phosphatase; D010744:Phosphoric Monoester Hydrolases; D001616:beta-Galactosidase; D019855:Ethylene Glycol; D004072:Digitonin